Replimune REPL
NASDAQ REPL
$13.24 +0.24 (+1.85%)
At close: Sep 30, 2026 · 4:00 PM EDT

Replimune (REPL) Cash from Financing Activities (2018 - 2026)

Updated

Replimune (REPL) reported Cash from Financing Activities of $800,000 for fiscal Q1 2027 (quarter ended Jun 30, 2026), compared with -$158,000 a year earlier and down 98.6% from the prior quarter.

Analysis

Replimune (REPL) Cash from Financing Activities (2018 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Replimune's Cash from Financing Activities came in at $67.25 million, down 56.8% year-over-year; for FY2026 (ended Mar 31, 2026), it was $66.29 million, down 73.7% from FY2025.

  • Cash from Financing Activities has a five-year compound annual growth rate of -29.2% (FY2021 to FY2026).
  • By fiscal year, Cash from Financing Activities came in at $252.4 million in FY2025, $16.28 million in FY2024 (-94.8%), $311.3 million in FY2023 and $6.6 million in FY2022 (-98.2%).
  • Five-year quarterly Cash from Financing Activities spans a low of -$158,000 in fiscal Q1 2026 and a high of $271.44 million in fiscal Q3 2023.
  • The high point for year-over-year Cash from Financing Activities in five years was fiscal Q3 2025 (growth of 948.6%); the low point was fiscal Q3 2022 (a decline of 98.5%).
  • Per Business Quant data, the three fiscal quarters before Q1 2027 came in at $55.68 million (Q4 2026), $10.45 million (Q3 2026) and $324,000 (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn -8.78 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn -5.05 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -47.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 2.34 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn -426.70 Mn
10 Replimune 1.09 Bn 1.09 Bn - 800,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 800,000.00
Mar 31, 2026 55.68 Mn
Dec 31, 2025 10.45 Mn
Sep 30, 2025 324,000.00
Jun 30, 2025 -158,000.00
Mar 31, 2025 -132,000.00
Dec 31, 2024 155.93 Mn
Sep 30, 2024 -39,000.00
Jun 30, 2024 96.64 Mn
Mar 31, 2024 -130,000.00
Dec 31, 2023 14.87 Mn
Sep 30, 2023 438,000.00
Jun 30, 2023 1.11 Mn
Mar 31, 2023 -77,000.00
Dec 31, 2022 271.44 Mn
Sep 30, 2022 7.42 Mn
Jun 30, 2022 32.52 Mn
Mar 31, 2022 359,000.00
Dec 31, 2021 3.97 Mn
Sep 30, 2021 1.15 Mn
API Access

Replimune Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=REPL&period=max&api_key=YOUR_API_KEY